Tumor and metastasis suppression by the human RNASET2 gene
- PMID: 15809705
Tumor and metastasis suppression by the human RNASET2 gene
Abstract
The region 6q27 from human chromosome 6 has been reported to contain one or more tumor suppressor genes on the basis of cytogenetic, molecular and functional studies. We have recently carried out a detailed analysis of a candidate gene from 6q27 to evaluate its putative role as a tumor suppressor gene involved in ovarian cancer pathogenesis. The RNASET2 gene was shown to behave as a class II tumor suppressor and abolish the tumorigenic potential of an ovarian cancer-derived cell line. In this study, we have started the cellular and biochemical characterization of RNASET2 and showed that it is a secreted glycoprotein. Moreover, we have extended our previous studies by evaluating the effect of RNASET2 on the metastatic behavior of the highly-invasive ovarian cancer cell line HEY3MET2. From such analysis, RNASET2 was found to significantly decrease the metastatic potential of this cell line in vivo. Moreover, RNASET2-mediated suppression of tumorigenesis and metastasis was not affected by a double point mutation targeted to the putative ribonuclease catalytic sites, suggesting that tumor suppression by RNASET2 is not mediated by its ribonuclease activity. The potential biological implications of this unexpected finding are discussed in relation to the current evolutionary models.
Similar articles
-
Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27.Oncogene. 2001 Feb 22;20(8):980-8. doi: 10.1038/sj.onc.1204178. Oncogene. 2001. PMID: 11314033
-
A recombinant human RNASET2 glycoprotein with antitumorigenic and antiangiogenic characteristics: expression, purification, and characterization.Cancer. 2006 Dec 15;107(12):2760-9. doi: 10.1002/cncr.22327. Cancer. 2006. PMID: 17109444
-
RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.Oncogene. 2007 Feb 1;26(5):683-700. doi: 10.1038/sj.onc.1209827. Epub 2006 Jul 31. Oncogene. 2007. PMID: 16878154
-
Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells.Oncotarget. 2011 Jun;2(6):477-84. doi: 10.18632/oncotarget.274. Oncotarget. 2011. PMID: 21646684 Free PMC article. Review.
-
Human RNASET2: A Highly Pleiotropic and Evolutionary Conserved Tumor Suppressor Gene Involved in the Control of Ovarian Cancer Pathogenesis.Int J Mol Sci. 2022 Aug 13;23(16):9074. doi: 10.3390/ijms23169074. Int J Mol Sci. 2022. PMID: 36012339 Free PMC article. Review.
Cited by
-
Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells.Int J Mol Sci. 2016 Aug 23;17(9):1387. doi: 10.3390/ijms17091387. Int J Mol Sci. 2016. PMID: 27563880 Free PMC article. Review.
-
tRNA biology charges to the front.Genes Dev. 2010 Sep 1;24(17):1832-60. doi: 10.1101/gad.1956510. Genes Dev. 2010. PMID: 20810645 Free PMC article. Review.
-
Overexpression of SMOC2 Attenuates the Tumorigenicity of Hepatocellular Carcinoma Cells and Is Associated With a Positive Postoperative Prognosis in Human Hepatocellular Carcinoma.J Cancer. 2017 Oct 17;8(18):3812-3827. doi: 10.7150/jca.20775. eCollection 2017. J Cancer. 2017. PMID: 29151969 Free PMC article.
-
Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents.Pharmaceutics. 2021 Jan 9;13(1):82. doi: 10.3390/pharmaceutics13010082. Pharmaceutics. 2021. PMID: 33435285 Free PMC article. Review.
-
RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection.Nat Genet. 2009 Jul;41(7):773-5. doi: 10.1038/ng.398. Epub 2009 Jun 14. Nat Genet. 2009. PMID: 19525954
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases